50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,635.82 (-0.53%)
DOW   29,057.98 (-0.69%)
QQQ   273.05 (-0.48%)
AAPL   151.28 (+0.34%)
MSFT   235.55 (-0.80%)
META   134.94 (-1.05%)
GOOGL   97.22 (-0.97%)
AMZN   113.71 (-1.25%)
TSLA   279.62 (+1.31%)
NVDA   123.34 (+0.87%)
NIO   17.07 (-3.12%)
BABA   77.27 (-2.08%)
AMD   66.39 (+0.14%)
T   15.76 (+0.57%)
MU   49.89 (+2.07%)
CGC   2.78 (+1.46%)
F   11.75 (-2.00%)
GE   63.78 (-0.89%)
DIS   96.35 (-1.80%)
AMC   7.06 (+3.37%)
PYPL   85.04 (+0.93%)
PFE   43.94 (+0.25%)
NFLX   222.20 (-0.83%)
S&P 500   3,635.82 (-0.53%)
DOW   29,057.98 (-0.69%)
QQQ   273.05 (-0.48%)
AAPL   151.28 (+0.34%)
MSFT   235.55 (-0.80%)
META   134.94 (-1.05%)
GOOGL   97.22 (-0.97%)
AMZN   113.71 (-1.25%)
TSLA   279.62 (+1.31%)
NVDA   123.34 (+0.87%)
NIO   17.07 (-3.12%)
BABA   77.27 (-2.08%)
AMD   66.39 (+0.14%)
T   15.76 (+0.57%)
MU   49.89 (+2.07%)
CGC   2.78 (+1.46%)
F   11.75 (-2.00%)
GE   63.78 (-0.89%)
DIS   96.35 (-1.80%)
AMC   7.06 (+3.37%)
PYPL   85.04 (+0.93%)
PFE   43.94 (+0.25%)
NFLX   222.20 (-0.83%)
S&P 500   3,635.82 (-0.53%)
DOW   29,057.98 (-0.69%)
QQQ   273.05 (-0.48%)
AAPL   151.28 (+0.34%)
MSFT   235.55 (-0.80%)
META   134.94 (-1.05%)
GOOGL   97.22 (-0.97%)
AMZN   113.71 (-1.25%)
TSLA   279.62 (+1.31%)
NVDA   123.34 (+0.87%)
NIO   17.07 (-3.12%)
BABA   77.27 (-2.08%)
AMD   66.39 (+0.14%)
T   15.76 (+0.57%)
MU   49.89 (+2.07%)
CGC   2.78 (+1.46%)
F   11.75 (-2.00%)
GE   63.78 (-0.89%)
DIS   96.35 (-1.80%)
AMC   7.06 (+3.37%)
PYPL   85.04 (+0.93%)
PFE   43.94 (+0.25%)
NFLX   222.20 (-0.83%)
S&P 500   3,635.82 (-0.53%)
DOW   29,057.98 (-0.69%)
QQQ   273.05 (-0.48%)
AAPL   151.28 (+0.34%)
MSFT   235.55 (-0.80%)
META   134.94 (-1.05%)
GOOGL   97.22 (-0.97%)
AMZN   113.71 (-1.25%)
TSLA   279.62 (+1.31%)
NVDA   123.34 (+0.87%)
NIO   17.07 (-3.12%)
BABA   77.27 (-2.08%)
AMD   66.39 (+0.14%)
T   15.76 (+0.57%)
MU   49.89 (+2.07%)
CGC   2.78 (+1.46%)
F   11.75 (-2.00%)
GE   63.78 (-0.89%)
DIS   96.35 (-1.80%)
AMC   7.06 (+3.37%)
PYPL   85.04 (+0.93%)
PFE   43.94 (+0.25%)
NFLX   222.20 (-0.83%)
EPA:GNFT

Genfit - GNFT Stock Forecast, Price & News

€3.76
-0.04 (-1.05%)
(As of 09/26/2022 12:00 AM ET)
Add
Compare
Today's Range
€3.71
€3.83
50-Day Range
€3.81
€4.69
52-Week Range
N/A
Volume
92,526 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GNFT stock logo

About Genfit (EPA:GNFT) Stock

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.

Receive GNFT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genfit and its competitors with MarketBeat's FREE daily newsletter.

GNFT Stock News Headlines

GNFT Genfit S.A.
Genfit reports Q1 results
Genfit GAAP EPS of €1.23, revenue of €85.58M
GENFIT S.A. American Depositary Shares (GNFT)
Why Genfit Shares Are Rising
Pre-market Movers: GNFT, ABEO, SPRB, IO, CERN…
GENFIT: Publication of the 2020 Universal...
GENFIT: 2021 Financial Calendar
See More Headlines
Receive GNFT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genfit and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Jean-Francois Mouney (Age 67)
    Co-Founder & Chairman
    Comp: $332.42k
  • Mr. M. Pascal Prigent (Age 54)
    Chief Exec. Officer
    Comp: $503.74k
  • Prof. Bart Staels (Age 59)
    Co-Founder & Chairman of the Scientific Advisory Board
  • Mr. Thomas Baetz (Age 48)
    Chief Financial Officer
  • Mr. Pascal Caisey (Age 54)
    Chief Operating Officer
  • Dr. Dean W. Hum Ph.D. (Age 60)
    Chief Scientific Officer
  • Mr. Laurent Lannoo (Age 52)
    Corp. Sec. & Director of Legal Affairs
  • Ms. Stefanie Magner (Age 41)
    Chief Compliance Officer & VP of International Legal Affairs
  • Ms. Emilie Desodt (Age 39)
    Vice-Pres of HR
  • Mr. Jean-Christophe Marcoux (Age 45)
    Chief Strategy Officer













GNFT Stock - Frequently Asked Questions

How have GNFT shares performed in 2022?

Genfit's stock was trading at €4.32 on January 1st, 2022. Since then, GNFT stock has decreased by 12.8% and is now trading at €3.76.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Genfit own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genfit investors own include Alimentation Couche-Tard (ATD.B), Aecon Group (ARE), Algonquin Power & Utilities (AQN), Aptiv (APTV), American Tower (AMT), Advanced Micro Devices (AMD), Ambarella (AMBA), Albemarle (ALB), Adobe (ADBE) and Abbott Laboratories (ABT).

What is Genfit's stock symbol?

Genfit trades on the EPA under the ticker symbol "GNFT."

What is Genfit's stock price today?

One share of GNFT stock can currently be purchased for approximately €3.76.

How many employees does Genfit have?

The company employs 122 workers across the globe.

How can I contact Genfit?

Genfit's mailing address is Parc Eurasante 885 avenue Eugene Avinee, Loos, Hauts De France 59120. The official website for the company is www.genfit.com. The company can be reached via phone at 33 3 20 16 40 00.

This page (EPA:GNFT) was last updated on 9/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.